Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT02839291
NA
Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
Sponsor: Centre Hospitalier Universitaire de Besancon
View on ClinicalTrials.gov
Summary
To evaluate the current medical practice and its influence on health-related quality of life, in patients who are treated with injectable bone antiresorptive drugs (biphosphonates or denosumab) for at least one year.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
148
Start Date
2016-06-14
Completion Date
2025-01-31
Last Updated
2024-12-27
Healthy Volunteers
No
Conditions
Interventions
OTHER
quality of life questionaries
DRUG
intravenous or oral bone antiresorptive treatments
Locations (2)
Centre Hospitalier Régional Universitaire de Besançon
Besançon, France
Hôpital Nord Franche-Comté
Montbéliard, France